Retevmo 00002-2980
Generic: Selpercatinib
Product NDC
00002-2980- Manufacturer
- Eli Lilly And Company
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 8, 2020
- Listing Expires
- December 31, 2026
- Application
- NDA213246
Need to source Retevmo? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Selpercatinib | 80 mg/1 |
Drug Class
Kinase Inhibitor [EPC]Breast Cancer Resistance Protein Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Packaging Options(2)
120 CAPSULE in 1 BOTTLE (0002-2980-26)
60 CAPSULE in 1 BOTTLE (0002-2980-60)